We demonstrate that BRCA1 hypermethylation is twice as frequent as BRCA1-null tumors in early-stage unselected TNBC and that elevated BRCA1 promoter methylation is detectable in peripheral blood DNA of patients with hypermethylation in the tumor. The gene discussed is BRCA1; the disease is neoplasm.